Síndrome linfoproliferativo CD30+ cutáneo primario

Falini, 1995, CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy, Blood, 85, 1, 10.1182/blood.V85.1.1.bloodjournal8511 Schwab, 1982, Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells, Nature, 299, 65, 10.1038/299065a0 Kempf, 2006, CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators, J Cutan Pathol, 33, 58, 10.1111/j.0303-6987.2006.00548.x Fischer, 1988, A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor beta-chain gene, Blood, 72, 234, 10.1182/blood.V72.1.234.234 Le Beau, 1989, The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma, Leukemia, 3, 866 Willemze, 1997, EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood, 90, 354 Willemze, 2005, WHO-EORTC classification for cutaneous lymphomas, Blood, 105, 3768, 10.1182/blood-2004-09-3502 Bekkenk, 2000, Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment, Blood, 95, 3653, 10.1182/blood.V95.12.3653 Ortiz Romero, 1991 Ortiz Romero, 1992, Lymphomatoid papulosis: a study of 18 cases, J Eur Acad Dermatol Venereol, 1, 205, 10.1111/j.1468-3083.1992.tb00634.x Gallardo, 2004, Diagnóstico y tratamiento de los linfomas cutáneos de células T primarios, Actas Dermosifiliogr, 95, 473, 10.1016/S0001-7310(04)76864-7 Kempf, 2006, CD30+ T-cell lymphoproliferative disorders, 179 Kadin, 2006, Pathobiology of CD30+ cutaneous T-cell lymphomas, J Cutan Pathol, 33, 10, 10.1111/j.0303-6987.2006.00507.x Ortiz Romero, 1997, Absence of HTLV-1 proviral sequences in patients with lymphomatoid papulosis, J Invest Dermatol, 109, 817, 10.1111/1523-1747.ep12341032 Kempf, 2003, Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin, Carcinogenesis, 24, 301, 10.1093/carcin/24.2.301 Sánchez, 1990, Papulosis linfomatoide: análisis clínico, histológico, inmunohistoquímico y de reordenamiento del receptor de la cadena beta del receptor del linfocito T de 15 casos, Actas Dermosifiliogr, 81, 323 Marrero-Calvo, 2007, Primary cutaneous anaplastic CD30+ large cell lymphoma, Actas Dermosifiliogr, 98, 194, 10.1016/S0001-7310(07)70045-5 Gómez Díez, 2001, Transformación de la micosis fungoide/síndrome de Sézary a linfoma de células grandes, Actas Dermosifiliogr, 92, 391, 10.1016/S0001-7310(01)76522-2 Steinhoff, 2002, Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin, Blood, 100, 578, 10.1182/blood-2001-12-0199 Gellrich, 2004, The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative), J Invest Dermatol, 122, 859, 10.1111/j.0022-202X.2004.22304.x Davis, 1992, Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone, N Engl J Med, 326, 1115, 10.1056/NEJM199204233261704 Kodama, 2005, Papular mycosis fungoides: a new clinical variant of early mycosis fungoides, J Am Acad Dermatol, 52, 694, 10.1016/j.jaad.2004.12.018 Sánchez, 1990, Papulosis linfomatoide folicular, Actas Dermosifiliogr, 81, 195 Savage, 2005, Aggressive peripheral T-cell lymphomas (specified and unspecified types), Hematology Am Soc Hematol Educ Program, 267, 10.1182/asheducation-2005.1.267 Forero, 2005, Initial phase II results of SGN-30 (anti-CD30 monoclonal antibody) in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL), J Clin Oncol, 23, 585s, 10.1200/jco.2005.23.16_suppl.6601 Whittaker, 2007, Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sézary syndrome variants of cutaneous T-cell lymphoma, Cancer Treat Rev, 33, 146, 10.1016/j.ctrv.2006.08.006 Bartlett, 2008, A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies, Blood, 111, 1848, 10.1182/blood-2007-07-099317 Shehan, 2004, Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma, J Am Acad Dermatol, 51, 103, 10.1016/j.jaad.2003.12.028 Droc, 2007, Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin, Cancer Control, 14, 124, 10.1177/107327480701400205